Joo-Yun Byun

Sungkyunkwan University

*This is an algorithmically generated author record based on publicly available information.

See Latest Publications

See Most Cited Publications

ORCID Profile

Google Scholar

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Sungkyunkwan University

Research Subjects

Research Interests

Joo-Yun Byun has a total of 48 co-authors. Here are the top co-authors by number of shared publications:

Himangshu Sonowal
Division of Surgical Oncology, Departmen of Surgery, UC San Diego, San Diego, California
38 shared publications
Rafael Bejar
Moores Cancer Center, UC San Diego, La Jolla, USA
38 shared publications
Ranjeet Sinha
Aptose Biosciences, Inc., San Diego, California
38 shared publications
Seung Hyun Jung
Hanmi R&D Center, Seoul, Korea
38 shared publications
Stephen B. Howell
University of California, San Diego
38 shared publications
William G. Rice
Aptose Biosciences, Inc., San Diego, California
38 shared publications

Latest Publications

Sort by

Open Access
Website
Google Scholar
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
by Himangshu Sonowal, William G. Rice, Raphael Bejar, Joo-Yun Byun, Seung Hyun Jung, Ranjeet Sinha, Stephen B. Howell
Information on antibody RRID and Other catalog numbers
Website
Google Scholar
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Data from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
by Himangshu Sonowal, William G. Rice, Raphael Bejar, Joo-Yun Byun, Seung Hyun Jung, Ranjeet Sinha, Stephen B. Howell
Information on antibody RRID and Other catalog numbers
Open Access
Website
Google Scholar
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Suppl Figure 1 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
by Himangshu Sonowal, William G. Rice, Raphael Bejar, Joo-Yun Byun, Seung Hyun Jung, Ranjeet Sinha, Stephen B. Howell
Suppl Figure 1 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
Website
Google Scholar
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Suppl Figure 1 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
by Himangshu Sonowal, William G. Rice, Raphael Bejar, Joo-Yun Byun, Seung Hyun Jung, Ranjeet Sinha, Stephen B. Howell
Suppl Figure 1 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
Open Access
Website
Google Scholar
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Suppl Figure 3 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
by Himangshu Sonowal, William G. Rice, Raphael Bejar, Joo-Yun Byun, Seung Hyun Jung, Ranjeet Sinha, Stephen B. Howell
Suppl Figure 3 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
Website
Google Scholar
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Suppl Figure 3 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
by Himangshu Sonowal, William G. Rice, Raphael Bejar, Joo-Yun Byun, Seung Hyun Jung, Ranjeet Sinha, Stephen B. Howell
Suppl Figure 3 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
Open Access
Website
Google Scholar
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Tables from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
by Himangshu Sonowal, William G. Rice, Raphael Bejar, Joo-Yun Byun, Seung Hyun Jung, Ranjeet Sinha, Stephen B. Howell
Supplementary Table file to be published with manuscript
Website
Google Scholar
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Tables from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
by Himangshu Sonowal, William G. Rice, Raphael Bejar, Joo-Yun Byun, Seung Hyun Jung, Ranjeet Sinha, Stephen B. Howell
Supplementary Table file to be published with manuscript
Open Access
Website
Google Scholar
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Suppl Figure 4 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
by Himangshu Sonowal, William G. Rice, Raphael Bejar, Joo-Yun Byun, Seung Hyun Jung, Ranjeet Sinha, Stephen B. Howell
Suppl Figure 4 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
Website
Google Scholar
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Suppl Figure 4 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
by Himangshu Sonowal, William G. Rice, Raphael Bejar, Joo-Yun Byun, Seung Hyun Jung, Ranjeet Sinha, Stephen B. Howell
Suppl Figure 4 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
Open Access
Website
Google Scholar
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Suppl Figure 8 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
by Himangshu Sonowal, William G. Rice, Raphael Bejar, Joo-Yun Byun, Seung Hyun Jung, Ranjeet Sinha, Stephen B. Howell
Suppl Figure 8 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
Website
Google Scholar
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Suppl Figure 8 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
by Himangshu Sonowal, William G. Rice, Raphael Bejar, Joo-Yun Byun, Seung Hyun Jung, Ranjeet Sinha, Stephen B. Howell
Suppl Figure 8 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
Open Access
Website
Google Scholar
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Suppl Figure 6 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
by Himangshu Sonowal, William G. Rice, Raphael Bejar, Joo-Yun Byun, Seung Hyun Jung, Ranjeet Sinha, Stephen B. Howell
Suppl Figure 6 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
Website
Google Scholar
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Suppl Figure 6 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
by Himangshu Sonowal, William G. Rice, Raphael Bejar, Joo-Yun Byun, Seung Hyun Jung, Ranjeet Sinha, Stephen B. Howell
Suppl Figure 6 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
Open Access
Website
Google Scholar
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Suppl Figure 2 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
by Himangshu Sonowal, William G. Rice, Raphael Bejar, Joo-Yun Byun, Seung Hyun Jung, Ranjeet Sinha, Stephen B. Howell
Suppl Figure 2 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
Website
Google Scholar
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Suppl Figure 2 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
by Himangshu Sonowal, William G. Rice, Raphael Bejar, Joo-Yun Byun, Seung Hyun Jung, Ranjeet Sinha, Stephen B. Howell
Suppl Figure 2 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
Open Access
Website
Google Scholar
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Suppl Figure 5 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
by Himangshu Sonowal, William G. Rice, Raphael Bejar, Joo-Yun Byun, Seung Hyun Jung, Ranjeet Sinha, Stephen B. Howell
Suppl Figure 5 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
Website
Google Scholar
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Suppl Figure 5 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
by Himangshu Sonowal, William G. Rice, Raphael Bejar, Joo-Yun Byun, Seung Hyun Jung, Ranjeet Sinha, Stephen B. Howell
Suppl Figure 5 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
Open Access
Website
Google Scholar
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Suppl Figure 7 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
by Himangshu Sonowal, William G. Rice, Raphael Bejar, Joo-Yun Byun, Seung Hyun Jung, Ranjeet Sinha, Stephen B. Howell
Suppl Figure 7 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
Website
Google Scholar
- 13 May 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Suppl Figure 7 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia
by Himangshu Sonowal, William G. Rice, Raphael Bejar, Joo-Yun Byun, Seung Hyun Jung, Ranjeet Sinha, Stephen B. Howell
Suppl Figure 7 from Preclinical Development of Tuspetinib for the Treatment of Acute Myeloid Leukemia

Show all